In the last 10 years, there has been significant development in computer simulation of pharmaceutical materials, processes and product performance. Gradually, more mechanistically based models are ...
Formulation scientists are behind the conversion of active pharmaceutical ingredients (API) into stable, bioavailable, and commercially viable dosage forms, rarely a simple process. Image Credit: ...
Stability is a critical factor in drug formulation, with implications for product quality, lifecycle management, and ...
AI/ML technologies are revolutionizing pharmaceutical formulation by optimizing excipient selection and predicting stability, reducing time and resources needed for development. Poor solubility of ...
PharmTech spoke with Dr. Asma Patel, VP Global Commercial and Scientific Consulting–Drug Product, to find out how the growth ...
The protein therapeutics market totaled $63 billion in 2007 ($39 billion in the U.S. alone) and is expected to reach $87 billion by 2010, according to a report by Kalorama Information—“Protein ...
Patients with some cancers, autoimmune diseases, and metabolic disorders often endure time-consuming intravenous (IV) infusions to receive the best protein-based treatments available. Because these ...
(MENAFN- Market Press Release) August 20, 2023 9:42 pm - When designing pharmaceutical preparations, the choice of excipients should not only consider the dosage form factors and excipient functions ...
Firms will offer integrated solutions for multiparticulate oral controlled-release products. Drug formulation and delivery specialists Bend Research and Catalent Pharma Solutions inked an agreement to ...
Early on, the drug substance (DS) manufacturer will provide a wealth of preliminary characterization data. And if the drug is active in early nonclinical and preclinical testing, a larger quantity of ...
Sponsored by Specac LtdReviewed by Maria OsipovaOct 15 2025 Formulation scientists are behind the conversion of active pharmaceutical ingredients (API) into stable, bioavailable, and commercially ...